Investegate |NetScientific PLC Announcements | NetScientific PLC: $60m Commitment for PDS Vaccine Consortium
c. $60m Funding Commitment by Brazilian government for Clinical Development and Commercialisation of PDS Consortium's COVID-19 Vaccine London, UK - 11 March 2021 - NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that PDS Biotech's proprietary Versamune®T-cell activating technology, today announced that its COVID-19 vaccine consortium jointly run by PDS consisting of Farmacore Biotechnology and Blanver Farmoquímica, has received a commitment from the Secretary for Research...